The effects of lipolysis of human plasma very low density lipoprotein (VLDL) on the structure and composition of high density lipoproteins (HDL) have been investigated. Lipolysis was performed in a controlled system in vitro containing VLDL (d < 1.006 g/ml) and HDL3 (d = 1.125-1.210 g/ml) from human plasma and lipoprotein lipase (EC 3.1.1.34) purified from bovine milk. The high density lipoproteins (HDL) represent one of the four major families of plasma lipoproteins that circulate in human plasma. The HDL have become the focus of much interest since their plasma concentrations have been shown to be inversely correlated with the risk of coronary heart disease (1-3). This correlation is an epidemiologic observation; the mechanism(s) by which HDL protect against atherosclerosis is unknown although several have been suggested (1, 4). A detailed knowledge of the metabolism of HDL is essential for elucidating this mechanism. The pathways of HDL synthesis and degradation in human beings are poorly understood. In animal experiments with isolated perfused rat liver (5) and with rat intestinal lymph (6) a type of HDL resembling a bilayered disc has been isolated. This particle has been called nascent HDL. Hamilton et al. (5) have suggested that the discoidal nascent HDL are transformed to spherical particles characteristic of HDL by the intravascular action of lysolecithin acyltransferase (EC 2.3.1.23). ApoA-I, the major protein of HDL, can be synthesized in rat intestine (6) and is found in the lymph associated both with chylomicrons and nascent HDL. When chylomicrons enter the plasma, apoA-I is transferred to circulating HDL (7). The source of the lipids necessary to form the HDL particles with apoA-I has not been elucidated.HDL can be divided into at least two subfractions, HDL2 and HDL3, which are traditionally isolated at density intervals of 1.063-1.125 and 1.125-1.210 g/ml, respectively (8). HDL2 particles are larger and contain a larger proportion of lipids than do the HDL3 (9, 10). Whether HDL2 and HDL3 are metabolically interrelated is not known. The present study was undertaken to test the hypothesis that the lipid and apoprotein constituents formed in the degradation of triglyceride-rich lipoproteins may contribute to the mass of HDL. We now report the transformation of human plasma HDL3 to an HDL2-like particle in a controlled lipolysis system in vitro when very low density lipoproteins (VLDL) and HDL3 are incubated with lipoprotein lipase (EC 3.1.1.34).
MATERIALS AND METHODS Preparation of Lipoproteins and Labeled Lipoproteins.Plasma lipoproteins were isolated from normal human subjects. The plasma was obtained by plasmapheresis after a 12-to 14-hr fast of individuals whose plasma cholesterol and triglyceride concentrations ranged from 160 to 200 mg/dl and 150 to 200 mg/dl, respectively. VLDL were isolated at plasma density by ultracentrifugation in a Beckman L2-65B ultracentrifuge with a Beckman 6OTi rotor at 50,000 rpm for 18 hr at 40 followed by ultracentrifugation in a Beckman SW41 swinging b...